相似文献
1
EGFR/EGFRvIII partly regulates the tumourigenesis of glioblastoma through the SOX9-GLUT3 axis.
Am J Transl Res. 2021 Jun 15;13(6):6055-6065. eCollection 2021.
2
Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma.
Mol Cancer. 2013 Apr 25;12:31. doi: 10.1186/1476-4598-12-31.
3
Generation of humanized single-chain fragment variable immunotherapeutic against EGFR variant III using baculovirus expression system and in vitro validation.
Int J Biol Macromol. 2019 Mar 1;124:17-24. doi: 10.1016/j.ijbiomac.2018.11.202. Epub 2018 Nov 22.
4
SHP-2-dependent mitogen-activated protein kinase activation regulates EGFRvIII but not wild-type epidermal growth factor receptor phosphorylation and glioblastoma cell survival.
Cancer Res. 2004 Nov 15;64(22):8292-8. doi: 10.1158/0008-5472.CAN-03-3143.
5
Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells.
Mol Ther Nucleic Acids. 2018 Mar 2;10:438-449. doi: 10.1016/j.omtn.2018.01.001. Epub 2018 Jan 8.
6
Selective Targeting of Glioblastoma with EGFRvIII/EGFR Bitargeted Chimeric Antigen Receptor T Cell.
Cancer Immunol Res. 2018 Nov;6(11):1314-1326. doi: 10.1158/2326-6066.CIR-18-0044. Epub 2018 Sep 10.
7
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2.
8
Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.
Clin Cancer Res. 2004 May 1;10(9):3216-24. doi: 10.1158/1078-0432.ccr-03-0521.
9
EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells.
Oncotarget. 2015 Oct 20;6(32):33867-77. doi: 10.18632/oncotarget.5293.
10
C/EBPβ promotes angiogenesis through secretion of IL-6, which is inhibited by genistein, in EGFRvIII-positive glioblastoma.
Int J Cancer. 2015 Jun 1;136(11):2524-34. doi: 10.1002/ijc.29319. Epub 2014 Nov 26.
引用本文的文献
1
Decoding EGFR A289 Mutation in Glioblastoma: A Predictive Biomarker Framework and Targeted Therapeutic Insights.
J Mol Neurosci. 2025 Jul 12;75(3):88. doi: 10.1007/s12031-025-02381-0.
2
A High Throughput Screen with a Clonogenic Endpoint to Identify Radiation Modulators of Cancer.
Radiat Res. 2023 Feb 1;199(2):132-147. doi: 10.1667/RADE-22-00086.1.
3
Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma.
Cancers (Basel). 2022 Nov 1;14(21):5386. doi: 10.3390/cancers14215386.
4
Comprehensive Analysis of the Role of on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.
Anal Cell Pathol (Amst). 2022 Sep 19;2022:2371057. doi: 10.1155/2022/2371057. eCollection 2022.
本文引用的文献
1
Reciprocal control of ADAM17/EGFR/Akt signaling and miR-145 drives GBM invasiveness.
J Neurooncol. 2020 Apr;147(2):327-337. doi: 10.1007/s11060-020-03453-4. Epub 2020 Mar 13.
2
EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
Oncogene. 2020 Apr;39(14):2975-2986. doi: 10.1038/s41388-020-1199-2. Epub 2020 Feb 7.
3
Ecotropic viral integration site 1 regulates EGFR transcription in glioblastoma cells.
J Neurooncol. 2019 Nov;145(2):223-231. doi: 10.1007/s11060-019-03310-z. Epub 2019 Oct 15.
4
SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
Cancer Lett. 2020 Jan 1;468:14-26. doi: 10.1016/j.canlet.2019.10.004. Epub 2019 Oct 7.
5
microRNA-605 directly targets SOX9 to alleviate the aggressive phenotypes of glioblastoma multiforme cell lines by deactivating the PI3K/Akt pathway.
Onco Targets Ther. 2019 Jul 8;12:5437-5448. doi: 10.2147/OTT.S213026. eCollection 2019.
6
Antitumor efficacy of chimeric antigen receptor T cells against EGFRvIII-expressing glioblastoma in C57BL/6 mice.
Biomed Pharmacother. 2019 May;113:108734. doi: 10.1016/j.biopha.2019.108734. Epub 2019 Mar 5.
7
Generation of humanized single-chain fragment variable immunotherapeutic against EGFR variant III using baculovirus expression system and in vitro validation.
Int J Biol Macromol. 2019 Mar 1;124:17-24. doi: 10.1016/j.ijbiomac.2018.11.202. Epub 2018 Nov 22.
8
Bone morphogenetic protein 2 alleviated intervertebral disc degeneration through mediating the degradation of ECM and apoptosis of nucleus pulposus cells via the PI3K/Akt pathway.
Int J Mol Med. 2019 Jan;43(1):583-592. doi: 10.3892/ijmm.2018.3972. Epub 2018 Nov 2.
9
Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development.
Mol Biol Cell. 2018 Nov 1;29(22):2784-2799. doi: 10.1091/mbc.E18-08-0488. Epub 2018 Sep 6.
10
TRIM59 Promotes Gliomagenesis by Inhibiting TC45 Dephosphorylation of STAT3.
Cancer Res. 2018 Apr 1;78(7):1792-1804. doi: 10.1158/0008-5472.CAN-17-2774. Epub 2018 Jan 31.
Zotero 插件